The directorship of each of Mr. Xue, Ms. Zhao and Mr. Fei will be subject to retirement and re-election at the first annual general meeting of the Company after their respective appointment, and the directorship of each of Mr. Xue, Ms. Zhao, Mr. Wu and Mr. Fei will also be subject to retirement by rotation and re-election at the annual general meeting of the Company in accordance with the articles of association of the Company and the Rules Governing the Listing of Securities on the Stock Exchange. The Board further announces that with effect from 18 July 2023: since Dr. Chen resigned as an independent non-executive Director, she will cease to be the chairman of the Nomination Committee and a member of each of the Audit Committee and Remuneration Committee; and Mr. Fei has been appointed as the chairman of the Nomination Committee and a member of each of the Audit Committee and Remuneration Committee.